Earnings History Data for Oncolytics Biotech Inc. (ONCY) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Oncolytics Biotech Inc.
Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-03-2024 | AH | ONCY | Oncolytics Biotech Inc. | 75.57 | -0.04 | -0.11 | -0.10 | Oncolytics Biotech GAAP EPS of -$0.05 beats by $0.06 [3/7/2024 4:39 PM] |
1.05 | 0.01 (0.96%) |
1.06 | 0.02 (1.92%) |
0.88 - 3.39 | 397,125 | 650,000 | 9,482 | ||
| 03-11-2023 | PM | ONCY | Oncolytics Biotech Inc. | 121.79 | -0.10 | -0.07 | -0.06 | Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.06 [11/3/2023 7:09 AM] |
1.71 | -0.08 (-4.47%) |
1.70 | -0.09 (-5.03%) |
1.09 - 3.39 | 458,376 | 440,000 | 18,759 | ||
| 14-08-2023 | PM | ONCY | Oncolytics Biotech Inc. | 135.66 | -0.09 | -0.09 | -0.07 | Oncolytics Biotech GAAP EPS of -C$0.12 [8/14/2023 9:05 AM] |
2.05 | 0.02 (0.99%) |
2.12 | 0.09 (4.43%) |
1.09 - 3.39 | 650,218 | 1,050,000 | 11,139 | ||
| 05-05-2023 | PM | 8:00 AM ET (May 5) |
ONCY | Oncolytics Biotech Inc. | 109.83 | -0.07 | -0.07 | -0.09 | Oncolytics Biotech GAAP EPS of -$0.10 in-line [5/5/2023 12:57 PM] |
1.62 | 0.17 (11.72%) |
1.53 | 0.08 (5.52%) |
0.80 - 2.28 | 225,089 | 230,000 | 14,654 | |
| 03-03-2023 | PM | 8:00 AM ET (Mar 3) |
ONCY | Oncolytics Biotech Inc. | 98.58 | -0.11 | -0.05 | -0.11 | Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.07 [3/3/2023 7:23 AM] |
1.60 | -0.08 (-4.76%) |
1.68 | 0.0 (0.00%) |
0.80 - 2.28 | 298,564 | 160,000 | 29,555 | |
| 07-11-2022 | PM | 7:00 AM ET (Nov 7) |
ONCY | Oncolytics Biotech Inc. | 72.33 | -0.06 | -0.09 | -0.07 | Oncolytics Biotech GAAP EPS of -C$0.08 in-line [11/7/2022 8:12 AM] |
1.51 | 0.25 (20.24%) |
1.43 | 0.17 (13.49%) |
0.80 - 2.11 | 495,794 | 40,000 | 40,251 | |
|
||||||||||||||||||
| 11-08-2022 | PM | 7:00 AM ET (Aug 11) |
ONCY | Oncolytics Biotech Inc. | 60.68 | -0.07 | -0.09 | -0.11 | Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01 [8/11/2022 7:02 AM] |
1.30 | 0.0 (0.00%) |
1.35 | 0.05 (3.89%) |
0.80 - 2.38 | 207,474 | 150,000 | 1,670 | |
| 05-05-2022 | AH | 4:00 PM ET (May 5) |
ONCY | Oncolytics Biotech Inc. | 79.39 | -0.09 | -0.13 | -0.10 | Oncolytics Biotech GAAP EPS of -$0.12 misses by $0.01 [5/5/2022 4:40 PM] |
1.36 | 0.0 (0.00%) |
1.33 | -0.10 (-6.99%) |
1.25 - 3.21 | 57,656 | 90,000 | 754 | |
|
||||||||||||||||||
| 03-03-2022 | AH | 4:00 PM ET (Mar 3) |
ONCY | Oncolytics Biotech Inc. | 93.55 | -0.11 | -0.14 | -0.16 | Oncolytics Biotech GAAP EPS of -C$0.14 [3/3/2022 4:10 PM] |
1.49 | -0.13 (-8.02%) |
1.73 | 0.01 (0.58%) |
1.25 - 4.83 | 376,210 | 230,000 | 2,277 | |
| 05-11-2021 | PM | 7:00 AM ET (Nov 5) |
ONCY | Oncolytics Biotech Inc. | 117.06 | -0.07 | -0.15 | -0.12 | Oncolytics Biotech reports Q3 results [11/5/2021 7:18 AM] |
2.09 | 0.06 (2.96%) |
2.20 | 0.17 (8.37%) |
1.87 - 4.83 | 223,715 | 190,000 | 11,654 | |
|
||||||||||||||||||
| 06-08-2021 | PM | 7:00 AM ET (Aug 6) |
ONCY | Oncolytics Biotech Inc. | 94.56 | -0.11 | -0.10 | -0.12 | Oncolytics Biotech EPS misses by $0.03 [8/6/2021 7:34 AM] |
2.23 | 0.04 (1.83%) |
2.20 | 0.01 (0.46%) |
1.52 - 4.83 | 226,753 | 150,000 | 13,122 | |
|
||||||||||||||||||
| 07-05-2021 | PM | ONCY | Oncolytics Biotech Inc. | 161.00 | -0.10 | -0.17 | 0.00 | Oncolytics Biotech reports Q1 results [5/7/2021 7:39 AM] |
2.86 | -0.06 (-2.05%) |
2.94 | 0.02 (0.69%) |
1.52 - 4.83 | 888,013 | 580,000 | 6,861 | ||
| 05-03-2021 | PM | 7:00 AM ET (Mar 5) |
ONCY | Oncolytics Biotech Inc. | 132.05 | -0.16 | -0.13 | -0.19 | Oncolytics Biotech EPS misses by $0.09 [3/5/2021 7:35 AM] |
2.69 | -0.36 (-11.81%) |
3.09 | 0.04 (1.31%) |
0.94 - 4.70 | 2,255,396 | 2,195,246 | 9,194 | |
| 11-11-2020 | AH | 4:00 PM ET (Nov 11) |
ONCY | Oncolytics Biotech Inc. | 89.98 | -0.12 | 0.00 | -0.12 | Oncolytics Biotech EPS misses by $0.06 [11/11/2020 4:02 PM] |
2.12 | -0.03 (-1.39%) |
2.19 | 0.04 (1.86%) |
0.82 - 6.02 | 289,908 | 428,496 | 42,132 | |
|
|
||||||||||||||||||
| 04-08-2020 | AH | 4:00 PM ET (Aug 4) |
ONCY | Oncolytics Biotech Inc. | 81.79 | -0.12 | -0.15 | -0.19 | Oncolytics Biotech EPS misses by $0.06 [8/4/2020 4:04 PM] |
2.00 | -0.15 (-6.98%) |
2.12 | -0.03 (-1.40%) |
0.35 - 6.02 | 654,070 | 480,154 | 10,523 | |
|
|
||||||||||||||||||